Article info
PDFORIGINAL ARTICLE
Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, placebo-controlled trial in 176 Korean subjects
- Address correspondence and reprint requests to: Address correspondence and reprint requests to: Jin Han Kang, MD, PhD, Department of Pediatrics, Division of Infectious Disease, Our Lady of Mercy Hospital, Seoul, Korea. Email: kjhan{at}olmh.cuk.ac.kr; and Sang Yoon Park, Branch of Uterine Cancer Research, National Cancer Center, Goyang, Korea. Email: parksang{at}ncc.re.kr
Citation
Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, placebo-controlled trial in 176 Korean subjects
Publication history
- First published August 1, 2008.
Online issue publication
March 06, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2008 Blackwell Publishing Ltd.